Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
Appointment
common cold

New experimental approach could stop common cold

September 17, 2019 Manufacturing and Production, Research and Development

Scientists believe they may have found a way to stop the common cold as instead of attacking the virus directly, …
News
shutterstock_212432119

Acceleron terminates drug candidate following facioscapulohumeral muscular dystrophy failure

September 17, 2019 Manufacturing and Production, Research and Development Acceleron, pharma, trial failure

Acceleron Pharma has seen its stock fall by almost 4% after it unveiled new Phase 2 data confirming that its …
News

Enlarged prostate drug may slow Parkinson’s disease

September 17, 2019 Manufacturing and Production, Research and Development Parkinson's, terazosin

A surprising find has led researchers to see that a drug used to treat enlarged prostates may also work as …
News

Novartis’ Cosentyx has strong Phase 3 interim showing in axial spondyloarthritis

September 17, 2019 Manufacturing and Production, Research and Development Cosentyx, Novartis, pharma

Novartis has highlighted new data from its ongoing Phase 3 trial into the efficacy and safety of itsinterleukin-17A inhibitor Cosentyx …
News
jerome-carle-general-manager-of-julphar-photo-aetos-wire

Jerome Carle steps down as Julphar Chief Executive

September 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug …
Appointment
lung_ambition_alliance

Breaking through limits in lung cancer: Introducing The Lung Ambition Alliance

September 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, Lung Ambition Alliance, lung cancer, oncology, pharma

Patrick Connor, VP and Global Franchise Head, Tumor Drivers and Resistance Mechanisms, at AstraZeneca, discusses his company’s role in the …
Feature
amgen_flag

Amgen’s Kyprolis + Darzalex combo shows progression-free survival benefit in multiple myeloma

September 16, 2019 Research and Development, Sales and Marketing Amgen, Kyrpolis, darzalex, multiple myeloma, pharma

Amgen has revealed new Phase 3 data for the combination of Kyprolis (carfilzomib) and Darzalex (daratumumab) in addition to the …
News

Novartis announce robust Phase 3 trials for ofatumumab in MS

September 16, 2019 Research and Development, Sales and Marketing Aubagio, Novartis, multiple sclerosis

Novartis’ multiple sclerosis candidate has demonstrated strong results in its Phase 3 ASCLEPIOS trials meeting primary endpoints and slashing the …
News

Multi-study data confirms Ocrevus’ long-term efficacy in reducing disability progression in multiple sclerosis

September 13, 2019 Medical Communications, Research and Development ECTRIMS, Ocrevus, Roche, multiple sclerosis, pharma

Roche has taken the opportunity at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Stockholm …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday again and time for another rundown of the top most popular articles on Pharmafile.com this week. This past …
News

UKRI Chief Executive Sir Mark Walport to step down in 2020

September 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UKRI, appointment, pharma

Sir Mark Walport, Chief Executive of UK Research and Innovation (UKRI), the national funding agency responsible for science and research …
News
images

Roche’s satralizumab succeeds in second positive study in rare CNS disease

September 12, 2019 Research and Development NMOSD, Roche, satralizumab

In a second pivotal Phase 3 study of Roche’s satralizumab, the drug showed itself to significantly reduce relapse risk for …
News
pharmafocus_sept_2019_cover

Read the September edition of Pharmafocus online now!

September 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, brexit, lung cancer, medicinal cannabis, pharma

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!With a new Prime …
News
371px-nhs-logo

UK cancer survival lagging behind other nations

September 12, 2019 Research and Development Cancer, british nhs

Cancer survival in the UK is falling behind other high-income nations, despite seeing an overall improvement in survival rates, according …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025